(SQM) Sociedad Quimica y Minera - Ratings and Ratios
Lithium, Iodine, Potassium, Specialty, Fertilizers, Industrial
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 45.8% |
| Value at Risk 5%th | 70.4% |
| Relative Tail Risk | -6.46% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.17 |
| Alpha | 41.92 |
| CAGR/Max DD | -0.16 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.464 |
| Beta | 0.965 |
| Beta Downside | 0.819 |
| Drawdowns 3y | |
|---|---|
| Max DD | 67.60% |
| Mean DD | 44.77% |
| Median DD | 50.50% |
Description: SQM Sociedad Quimica y Minera October 31, 2025
Sociedad Química y Minera de Chile S.A. (SQM) is a diversified Chile-based mining firm that produces specialty plant nutrients (e.g., sodium-potassium nitrate, blended fertilizers under the Ultrasol, Qrop and Speedfol brands), iodine derivatives for medical and industrial uses, and a broad portfolio of lithium chemicals-including lithium carbonate, lithium hydroxide and lithium chloride-critical for battery cathodes. The company also supplies industrial chemicals such as sodium nitrate, potassium nitrate, solar salts, and potassium chloride, and it markets third-party fertilizers while exploring copper, gold and silver deposits.
Key recent metrics: SQM shipped ~ 210,000 t of lithium carbonate and ~ 45,000 t of lithium hydroxide in 2023, generating roughly $2.3 billion in lithium sales and giving it a ~ 30 % share of the global lithium carbonate market. Fertilizer earnings benefited from a 7 % rise in global nitrogen-phosphate-potassium (NPK) demand driven by expanding agricultural output in Latin America. The firm’s 2024 capital-expenditure plan targets $1.5 billion to expand its Salar de Atacama lithium operations and to upgrade nitrate processing capacity, reflecting the twin secular trends of electric-vehicle battery growth and tightening nitrate export regulations.
If you want a deeper, data-rich view of SQM’s valuation dynamics, the ValueRay platform offers granular financial models and scenario analyses worth exploring.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (524.5m TTM) > 0 and > 6% of Revenue (6% = 259.6m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 5.31pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 82.42% (prev 77.60%; Δ 4.82pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 2.03b > Net Income 524.5m (YES >=105%, WARN >=100%) |
| Net Debt (3.22b) to EBITDA (1.01b) ratio: 3.20 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.82 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (285.7m) change vs 12m ago 0.00% (target <= -2.0% for YES) |
| Gross Margin 27.69% (prev 30.00%; Δ -2.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 37.59% (prev 42.22%; Δ -4.63pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.37 (EBITDA TTM 1.01b / Interest Expense TTM 186.3m) >= 6 (WARN >= 3) |
Altman Z'' 4.59
| (A) 0.30 = (Total Current Assets 5.52b - Total Current Liabilities 1.96b) / Total Assets 11.73b |
| (B) 0.33 = Retained Earnings (Balance) 3.90b / Total Assets 11.73b |
| (C) 0.09 = EBIT TTM 999.7m / Avg Total Assets 11.51b |
| (D) 0.88 = Book Value of Equity 5.48b / Total Liabilities 6.19b |
| Total Rating: 4.59 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 41.51
| 1. Piotroski 4.0pt |
| 2. FCF Yield 0.32% |
| 3. FCF Margin 1.52% |
| 4. Debt/Equity 0.86 |
| 5. Debt/Ebitda 3.20 |
| 6. ROIC - WACC (= -0.92)% |
| 7. RoE 9.87% |
| 8. Rev. Trend -67.59% |
| 9. EPS Trend -55.21% |
What is the price of SQM shares?
Over the past week, the price has changed by -4.76%, over one month by +28.72%, over three months by +33.58% and over the past year by +61.17%.
Is SQM a buy, sell or hold?
- Strong Buy: 6
- Buy: 4
- Hold: 5
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the SQM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 59.6 | -2.7% |
| Analysts Target Price | 59.6 | -2.7% |
| ValueRay Target Price | 69.3 | 13.1% |
SQM Fundamental Data Overview December 05, 2025
P/E Forward = 16.6389
P/S = 4.1636
P/B = 3.28
P/EG = 0.6869
Beta = 1.05
Revenue TTM = 4.33b USD
EBIT TTM = 999.7m USD
EBITDA TTM = 1.01b USD
Long Term Debt = 3.75b USD (from longTermDebt, last quarter)
Short Term Debt = 901.5m USD (from shortTermDebt, last quarter)
Debt = 4.71b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.22b USD (from netDebt column, last quarter)
Enterprise Value = 20.33b USD (18.01b + Debt 4.71b - CCE 2.39b)
Interest Coverage Ratio = 5.37 (Ebit TTM 999.7m / Interest Expense TTM 186.3m)
FCF Yield = 0.32% (FCF TTM 65.7m / Enterprise Value 20.33b)
FCF Margin = 1.52% (FCF TTM 65.7m / Revenue TTM 4.33b)
Net Margin = 12.12% (Net Income TTM 524.5m / Revenue TTM 4.33b)
Gross Margin = 27.69% ((Revenue TTM 4.33b - Cost of Revenue TTM 3.13b) / Revenue TTM)
Gross Margin QoQ = 29.48% (prev 24.32%)
Tobins Q-Ratio = 1.73 (Enterprise Value 20.33b / Total Assets 11.73b)
Interest Expense / Debt = 0.87% (Interest Expense 41.1m / Debt 4.71b)
Taxrate = 32.22% (85.6m / 265.6m)
NOPAT = 677.6m (EBIT 999.7m * (1 - 32.22%))
Current Ratio = 2.82 (Total Current Assets 5.52b / Total Current Liabilities 1.96b)
Debt / Equity = 0.86 (Debt 4.71b / totalStockholderEquity, last quarter 5.49b)
Debt / EBITDA = 3.20 (Net Debt 3.22b / EBITDA 1.01b)
Debt / FCF = 49.00 (Net Debt 3.22b / FCF TTM 65.7m)
Total Stockholder Equity = 5.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.47% (Net Income 524.5m / Total Assets 11.73b)
RoE = 9.87% (Net Income TTM 524.5m / Total Stockholder Equity 5.31b)
RoCE = 11.02% (EBIT 999.7m / Capital Employed (Equity 5.31b + L.T.Debt 3.75b))
RoIC = 6.79% (NOPAT 677.6m / Invested Capital 9.98b)
WACC = 7.71% (E(18.01b)/V(22.72b) * Re(9.57%) + D(4.71b)/V(22.72b) * Rd(0.87%) * (1-Tc(0.32)))
Discount Rate = 9.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.00%
[DCF Debug] Terminal Value 63.88% ; FCFE base≈65.7m ; Y1≈43.1m ; Y5≈19.7m
Fair Price DCF = 2.14 (DCF Value 306.3m / Shares Outstanding 142.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -55.21 | EPS CAGR: -14.62% | SUE: -0.06 | # QB: 0
Revenue Correlation: -67.59 | Revenue CAGR: 2.12% | SUE: 0.19 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.85 | Chg30d=+0.055 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=3.29 | Chg30d=+0.111 | Revisions Net=-1 | Growth EPS=+48.2% | Growth Revenue=+15.2%
Additional Sources for SQM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle